Search results
Author(s):
Thomas Engstrøm
Added:
1 day ago
EuroPCR 25 - 10-year outcomes from DANAMI-3-PRIMULTI show FFR-guided complete revascularisation in ST-elevation myocardial infarction (STEMI) reduces the risk of future events. We are joined by Dr Thomas Engstrøm (University of Copenhagen, Copenhagen, Denmark) to discuss 10-year outcomes from the multicenter, randomized DANAMI-3-PRIMULTI trial investigating FFR-guided complete…
View more
Author(s):
William E Boden
,
Juan Carlos Kaski
,
C Noel Bairey Merz
,
et al
Added:
3 weeks ago
Echo-stress in Myocardial Bridge
Author(s):
Priscilla Lamendola
,
Nello Cambise
,
Antonio Di Renzo
,
et al
Added:
11 months ago
Article
TCT 23: IFR SWEDEHEART
Author(s):
Matthias Gotberg
Added:
1 year ago
Video
Author(s):
Priscilla Lamendola
,
Nello Cambise
,
Antonio Di Renzo
,
et al
Added:
9 months ago
TCT 23: PICSO-AMI-I
Author(s):
Giovanni Luigi Di Maria
Added:
1 year ago
Video
Author(s):
Nazli Okumus
,
Jeffrey L Carson
Added:
1 year ago
AHA 2023 — Investigator, Dr Jeffrey Carson (Rutgers University, US) joined Dr Nazli Okumus, CardioNerds Ambassador to discuss findings from the MINT trial (NCT02981407).The aim of this randomised, parallel assignment trial (Rutgers) is to compare liberal and restrictive red blood cell transfusion strategies in patients who have had an acute myocardial infarction (AMI) and are anemic…
View more
Author(s):
Filippo Gurgoglione
,
Giampaolo Niccoli
Added:
6 months ago
Added:
7 months ago
In this week's episode of Parallax, host Dr Ankur Kalra engages in a thought-provoking discussion with Dr Stephen Smith, a pioneer in electrocardiography and myocardial infarction diagnosis. They delve into the groundbreaking OMI/NOMI paradigm (Occlusion MI vs Non-Occlusion MI), challenging the traditional STEMI vs non-STEMI terminology that has long been the cornerstone of acute coronary…
View more
Author(s):
William Gray
Added:
3 weeks ago
Safety and effectiveness outcomes of a 3-in-1 carotid stent delivery system show no major strokes at 30-day and one-year follow ups and significantly low rates of clinically driven target lesion revascularisation at two years.Dr William Gray (Main Line Health, Pennsylvania, US) joins us to discuss the first European presentation of the two-year outcomes from PERFORMANCE II (NCT04201132; Contego…
View more